Coho Partners’s AbbVie ABBV Stock Holding History

Coho Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,464	Closed	-$237K	–	71
2022 Q4	$237K	Buy	+1,464	New	+$224K	﹤0.01%	71
2022 Q3	–	Sell	-1,531	Closed	-$234K	–	69
2022 Q2	$234K	Hold	1,531	–	–	﹤0.01%	68
2022 Q1	$248K	Sell	1,531 -16	-1%	-$2.32K	﹤0.01%	70
2021 Q4	$209K	Buy	+1,547	New	+$183K	﹤0.01%	81
2021 Q3	–	Sell	-2,153	Closed	-$243K	–	68
2021 Q2	$243K	Buy	+2,153	New	+$242K	﹤0.01%	66
2021 Q1	–	Sell	-2,235	Closed	-$239K	–	68
2020 Q4	$239K	Buy	+2,235	New	+$215K	﹤0.01%	66
2020 Q3	–	Sell	-2,368	Closed	-$232K	–	62
2020 Q2	$232K	Buy	+2,368	New	+$208K	0.01%	61
2020 Q1	–	Sell	-2,368	Closed	-$210K	–	62
2019 Q4	$210K	Buy	+2,368	New	+$197K	﹤0.01%	67
2019 Q2	–	Sell	-2,530	Closed	-$204K	–	55
2019 Q1	$204K	Sell	2,530 -11	-0.4%	-$900	﹤0.01%	53
2018 Q4	$234K	Hold	2,541	–	–	0.01%	56
2018 Q3	$240K	Buy	2,541 +53	+2%	+$5.03K	0.01%	55
2018 Q2	$231K	Sell	2,488 -112	-4%	-$10.9K	0.01%	56
2018 Q1	$246K	Sell	2,600 -21	-0.8%	-$2.31K	0.01%	53
2017 Q4	$253K	Sell	2,621 -35	-1%	-$3.3K	0.01%	53
2017 Q3	$236K	Buy	+2,656	New	+$202K	0.01%	51
2017 Q1	–	Sell	-4,190	Closed	-$262K	–	55
2016 Q4	$262K	Hold	4,190	–	–	0.01%	51
2016 Q3	$264K	Buy	4,190 +621	+17%	+$40.2K	0.01%	54
2016 Q2	$221K	Buy	+3,569	New	+$217K	0.01%	57

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Coho Partners's ABBV Position: Q1 2023 in Review

Coho Partners sold out of AbbVie (ABBV) in Q1 2023, closing a stake of 1,464 shares — an estimated $237K sold.

Coho Partners first reported a position in ABBV in Q2 2016 and held it in 18 quarters. The position peaked at $264K in Q3 2016. 3,138 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

Coho Partners reported no remaining AbbVie position as of Q1 2023 after selling out during the quarter.
Coho Partners sold 1,464 AbbVie shares in Q1 2023, an estimated $237K.
Coho Partners first reported a position in AbbVie in Q2 2016 and held it in 18 quarters.
Coho Partners's AbbVie position peaked at $264K in Q3 2016.
3,138 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on Coho Partners's 13F filing for Q1 2023, filed 25 Apr 2023.